Benchling

Benchling We’re on a mission to unlock the power of biotechnology. The world's most innovative biotech R&D org.

06/03/2025

🔥 When Patrick Hsu first spoke about CRISPR at Harvard, the room was so packed they had to call the fire marshal. He knew then: this was big. Now, he’s betting big on AI and open science.

From cofounding Arc Institute to launching the world’s largest AI model for biology, Patrick’s still going after high-impact problems — and building the future of research.

🎙️ Listen to his story, on our first episode of : https://www.benchling.com/transcribed/patrick-hsu-on-crispr-ai-open-science?utm_campaign=organic&utm_source=facebook&utm_medium=social

At Benchling, we’ve spent 13 years building software to support the scientists behind biotech’s biggest breakthroughs. N...
06/03/2025

At Benchling, we’ve spent 13 years building software to support the scientists behind biotech’s biggest breakthroughs. Now, we’re telling their stories.

Today, we’re launching , a new interview series spotlighting the leaders shaping the future of R&D.

We're bringing you their personal stories, hard-earned lessons, and visions for the future. Here’s why: https://www.benchling.com/transcribed/stories-about-the-humans-of-biotech?utm_campaign=organic&utm_source=facebook&utm_medium=social

🎙️ Watch our first episode: https://www.benchling.com/transcribed/patrick-hsu-on-crispr-ai-open-science?utm_campaign=organic&utm_source=facebook&utm_medium=social

Global biotech leader Moderna, Inc. is setting the new standard for AI-driven research, as they ready their scientists w...
05/07/2025

Global biotech leader Moderna, Inc. is setting the new standard for AI-driven research, as they ready their scientists with a unified R&D digital platform powered by Benchling.

Today we announce our expanded collaboration with Moderna, delivering on digital systems consolidation, data standardization, and automated workflows, all in service of a stronger foundation for AI — and ultimately, breakthroughs for patients. https://www.benchling.com/news/benchling-and-moderna-collaborate-ai-driven-research?utm_campaign=organic&utm_source=facebook&utm_medium=social

See how we’re building with Anthropic's Claude to set the new standard of AI in science: https://www.anthropic.com/custo...
05/06/2025

See how we’re building with Anthropic's Claude to set the new standard of AI in science: https://www.anthropic.com/customers/benchling

We’ve launched three assistants so far — each tackling a key challenge in R&D. And we’re just getting started.

04/24/2025

What if all of your experimental data combined with the world’s scientific literature could answer your next question in seconds? Today, we’re sharing a first look at Benchling’s Deep Research agent — an AI agent that searches and reasons across both your organization’s institutional knowledge and public data.

See what we’re building and why scientists need research agents purpose-built for science. https://www.benchling.com/blog/deep-research?utm_campaign=organic&utm_source=facebook&utm_medium=social

Interested in being an early tester? Join the waitlist: https://www.benchling.com/deep-research-waitlist?utm_campaign=organic&utm_source=facebook&utm_medium=social

03/25/2025

💡 Most execs talk about AI. Our co-founder dropped everything to build it. Since January, Ashu Singhal has been back to building full-time, focused on one mission: bringing practical AI to the lab.

Today, we’re launching Benchling’s data entry assistant, now in beta! Our latest AI-powered tool captures data from messy formats (like PDFs or legacy spreadsheets), and converts it into structured data in Benchling.

And this is just the beginning. Here's our vision for AI agents in science, what we’ve learned so far, and what’s ahead: https://www.benchling.com/blog/ai-agents-for-scientists?utm_campaign=organic&utm_source=facebook&utm_medium=social

Interested in our data entry assistant? Join the waitlist: https://www.benchling.com/data-entry-assistant-waitlist?utm_campaign=organic&utm_source=facebook&utm_medium=social

02/24/2025

“I think there's huge opportunity, not just to 10x the number of medicines that we get to market,” said Benchling CEO Sajith Wickramasekara on BBC News, "but to make every step of getting them through the process of drug research and development way faster, way more automated, and take fewer people.”

"The industry should be aiming for 500, not 50, drugs per year, and to do it faster,” said Sajith. “That's where we come in at Benchling. We build technology that makes R&D faster, and I think there's never been a greater need.”

He spoke with BBC News about biotech’s productivity challenges, the industry’s changing global landscape, and how technology like AI will fuel greater innovation.

Learn about Benchling: https://www.benchling.com/?utm_campaign=organic&utm_source=facebook&utm_medium=social

Address

680 Folsom Street, 8th Floor
San Francisco, CA
94107

Website

Alerts

Be the first to know and let us send you an email when Benchling posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category